Why the Distribution Looks the Way It Does
Healthcare costs don't spread evenly across a workforce. They follow a pattern that's been documented consistently across populations and plan sizes: a small number of people with serious conditions generate the vast majority of claims, while most covered employees generate relatively little in any given year.
The conditions at the top of the cost distribution are predictable. Cardiovascular disease. Cancer. Diabetes complications, including kidney failure that progresses to dialysis.Musculoskeletal conditions requiring surgery. High-risk pregnancies. Specialty drugs for rare diseases that run six figures annually.
Here's the part that matters most for self-funded employers: many of these high-cost episodes are not random. They are not sudden, unforeseeable events. They are the downstream result of conditions that progressed because no one intervened earlier.
A $75,000 hospitalization for a diabetic complication almost always follows years of uncontrolled blood sugar. A dialysis claim, which runs $85,000 to $100,000 annually, is nearly always preceded by years of chronic kidney disease that could have been slowed with proper management. A cardiac event in a 52-year-old employee rarely comes without warning signs that were present in the claims data long before the event occurred, if anyone had been looking.
The 5% problem is partly a cost problem. More fundamentally, it's a detection and intervention problem.
What Your Claims Data Is Actually Telling You
If you're self-funded and you have access to your claims data (which you should) that data contains a detailed picture of where your spend is concentrated and why.
A proper population health analysis will show you things that a standard renewal review simply won't.
It will show you your actual high-cost claimants by condition category, not by name, but by clinical profile. You'll know whether your top spend is in oncology, cardiovascular disease, musculoskeletal conditions, maternity, or specialty pharmacy. You'll know whether the conditions driving that spend are acute and largely unpredictable or chronic and potentially manageable.
It will show you your rising-risk population. These are employees who aren't generating catastrophic claims yet, but whose utilization patterns suggest they're heading in that direction. The employee who has had two emergency room visits in the past year for hypertension-related symptoms and no evidence of a primary care follow-up. The employee whose pharmacy claims show escalating diabetes medications but no endocrinology engagement. These individuals don't appear in a summary renewal report. They are very visible in a detailed claims analysis — and they're also the people where intervention still has a chance to change the outcome.
Each of these groups calls for a completely different response. Treating all of them as one undifferentiated workforce, which is exactly what broad wellness programs do, is a large part of why those programs don't move the cost needle.
The Problem With How Most Employers Respond
When employers recognize that a small number of employees is driving most of their healthcare cost, the instinct is usually to shift costs, higher deductibles, bigger employee premium contributions, narrower networks. The logic is that if employees have more financial exposure, they'll make more cost-conscious choices.
For employees with routine, manageable healthcare needs, cost-sharing does create some price sensitivity. But for the employees generating most of your spend, it does something different. It creates a barrier to the care that might keep their conditions from getting worse.
An employee managing early-stage kidney disease who faces a $3,500 deductible before coverage kicks in is not going to make a cost-conscious decision to see a nephrologist regularly.They're going to defer that care until something forces an emergency. At that point, the condition has progressed, your stop-loss is activated, and an intervention that might have worked two years ago is no longer on the table.
Cost-shifting is a real-time cost management tool that often creates larger future costs. It is not a root cause strategy.
The other common response is a wellness program, gym discounts, step challenges, health fairs, biometric screenings. These aren't bad. But they are overwhelmingly consumed by your already-healthy employees. The people generating most of your claims are rarely the ones logging their steps or attending the lunch-and-learn on nutrition.
What Root Cause Analysis Does Differently
A root cause approach to the 5%problem starts with a simple but different question: who is actually in my high-cost and rising-risk tiers, what conditions are driving their utilization, and what interventions have the best probability of changing their trajectory?
The key word is targeted. Instead of designing benefits programs for the average employee, which means they're optimized for no one in particular, a root cause approach builds different strategies for different risk tiers. Your high-cost population needs something different than your rising-risk population, who needs something different than your low-utilization employees who aren't engaging with the plan at all.Recognizing that distinction, and acting on it, is what separates a benefits strategy from a benefits program.
For a pre-diabetic employee in the rising-risk tier, the intervention might be intensive lifestyle modification, real coaching, real clinical oversight, real accountability over time, not a link to a wellness app. For an employee with uncontrolled hypertension who hasn't engaged with primary care, the intervention might mean removing the cost barriers to medication and follow-up visits. For someone with chronic musculoskeletal pain on a trajectory toward surgery, it might mean connecting them to a centers-of-excellence program that produces better outcomes at a lower cost.
None of this requires identifying specific individuals by name. A properly structured care management program, built around your actual claims data and risk profile, reaches the right people through the right channels without compromising privacy. That infrastructure exists. It's just not standard issue in most benefits programs.
The Numbers Behind Targeted Intervention
The landmark Diabetes PreventionProgram showed that intensive lifestyle intervention for pre-diabetic individuals reduced progression to full diabetes by 58 percent over three years. Given that the annual cost difference between managing a pre-diabetic employee and one with active diabetes, particularly with complications, can run $8,000to $15,000 per person, preventing even a handful of progressions in a500-person workforce produces real financial impact.
Proactive chronic kidney disease management can delay or prevent dialysis initiation for years in patients with early to mid-stage CKD. Dialysis costs $85,000 to $100,000 annually, per patient. The cost of managing CKD proactively is a fraction of that.
Redirecting planned surgical procedures to centers of excellence with bundled pricing can reduce per-procedure costs by 30 to 40 percent while improving outcomes and reducing the complication-driven claims that often follow suboptimal care.
What This Means for Your Benefits Strategy
If your current benefits advisor presents you with an annual renewal package without a detailed analysis of your claims concentration, without telling you where your spend is actually located and what's driving it, you're not getting the management that self-funding makes possible.
The question to bring to your next renewal is simple: what are we doing to address our sickest population, and what are we doing to keep others from joining that risk group? If your advisor doesn't have a concrete answer to both parts of that question, you have your answer.
Want to know what's actually driving your healthcare spend? Contact us for a benefits strategy assessment.We'll show you where your claims are concentrated, who's in your rising-risk population, and what targeted interventions could mean for your plan costs over the next three years.
About the Author: Genesys Health specializes in root cause benefits consulting for self-funded employers. We work with organizations of all shapes and sizes — from manufacturers and family offices to PE-backed companies and beyond — helping them transform benefits from a line item into a strategic asset.
